INNOVATIVE EYEWEAR, INC. Proceeds from Convertible Debt
INNOVATIVE EYEWEAR, INC. (LUCY) reported Proceeds from Convertible Debt of $48.14 thousand for the 1-month period ending 2023-01-31, per its 10-K filed 2025-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2025-03-24
- INNOVATIVE EYEWEAR, INC. proceeds from convertible debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. proceeds from convertible debt for the quarter ending 2022-09-30 was $230.00K, a 44.58% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. proceeds from convertible debt for the quarter ending 2022-06-30 was $510.00K.
- INNOVATIVE EYEWEAR, INC. proceeds from convertible debt for the quarter ending 2022-03-31 was $735.00K.
- INNOVATIVE EYEWEAR, INC. proceeds from convertible debt for fiscal 2022 was $1.48M, a 38.95% increase from fiscal 2021.
- INNOVATIVE EYEWEAR, INC. proceeds from convertible debt for fiscal 2021 was $1.06M.
| Period end | Proceeds from Convertible Debt 1 month | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2023-01-31 | $48.14K 10-K · filed 2025-03-24 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $230.00K derived: sum of 2 quarters · filed 2024-03-25 | $740.00K derived: sum of 3 quarters · filed 2024-03-25 | $1.48M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $740.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.48M 10-Q · filed 2023-11-14 | $2.02M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.25M 10-Q · filed 2023-08-11 | $1.79M derived: sum of 3 quarters · filed 2023-08-11 | $2.20M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $735.00K 10-Q · filed 2023-05-12 | $1.28M derived: sum of 2 quarters · filed 2023-05-12 | $1.69M derived: sum of 3 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $540.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $955.50K derived: sum of 2 quarters · filed 2023-03-24 | $1.06M 10-K · filed 2023-03-24 | ||
| 2021-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $521.00K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $106.00K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |